BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37435067)

  • 1. Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells.
    Zhao Z; Ding Y; Tran LJ; Chai G; Lin L
    Front Immunol; 2023; 14():1196892. PubMed ID: 37435067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining bulk and scRNA-seq to explore the molecular mechanisms governing the distinct efferocytosis activities of a macrophage subpopulation in PDAC.
    Zhu S; Cheng Q; Zou M; Li C; Tang Y; Xia L; Jiang Y; Gong Z; Tang Z; Tang Y; Luo H; Peng N; Wang X; Dong X
    J Cell Mol Med; 2024 Apr; 28(7):e18266. PubMed ID: 38501838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of immunogenic cell death in ascending thoracic aortic aneurysms based on single-cell sequencing data.
    Tian Z; Zhang P; Li X; Jiang D
    Front Immunol; 2023; 14():1087978. PubMed ID: 37207221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment.
    Grote S; Ureña-Bailén G; Chan KC; Baden C; Mezger M; Handgretinger R; Schleicher S
    Cells; 2021 Apr; 10(5):. PubMed ID: 33925968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
    Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
    JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis.
    Frazao A; Rethacker L; Jeudy G; Colombo M; Pasmant E; Avril MF; Toubert A; Moins-Teisserenc H; Roelens M; Dalac S; Maubec E; Caignard A
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32912923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical-mediated discovery of pyroptosis in CD8
    Zhang Y; Bai Y; Ma XX; Song JK; Luo Y; Fei XY; Ru Y; Luo Y; Jiang JS; Zhang Z; Yang D; Xue TT; Zhang HP; Liu TY; Xiang YW; Kuai L; Liu YQ; Li B
    Cell Death Dis; 2023 Aug; 14(8):553. PubMed ID: 37620327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Immune Related Genes and Possible Regulatory Mechanisms in Alzheimer's Disease.
    Lu Y; Li K; Hu Y; Wang X
    Front Immunol; 2021; 12():768966. PubMed ID: 34804058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the treatment-naive immune microenvironment in melanoma with
    Wang M; Zadeh S; Pizzolla A; Thia K; Gyorki DE; McArthur GA; Scolyer RA; Long G; Wilmott JS; Andrews MC; Au-Yeung G; Weppler A; Sandhu S; Trapani JA; Davis MJ; Neeson PJ
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
    Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
    Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma.
    Jones NM; Yang H; Zhang Q; Morales-Tirado VM; Grossniklaus HE
    BMC Cancer; 2019 May; 19(1):484. PubMed ID: 31117965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients.
    Cursons J; Souza-Fonseca-Guimaraes F; Foroutan M; Anderson A; Hollande F; Hediyeh-Zadeh S; Behren A; Huntington ND; Davis MJ
    Cancer Immunol Res; 2019 Jul; 7(7):1162-1174. PubMed ID: 31088844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production.
    Laurent S; Queirolo P; Boero S; Salvi S; Piccioli P; Boccardo S; Minghelli S; Morabito A; Fontana V; Pietra G; Carrega P; Ferrari N; Tosetti F; Chang LJ; Mingari MC; Ferlazzo G; Poggi A; Pistillo MP
    J Transl Med; 2013 May; 11():108. PubMed ID: 23634660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.
    Chauvin JM; Ka M; Pagliano O; Menna C; Ding Q; DeBlasio R; Sanders C; Hou J; Li XY; Ferrone S; Davar D; Kirkwood JM; Johnston RJ; Korman AJ; Smyth MJ; Zarour HM
    Clin Cancer Res; 2020 Oct; 26(20):5520-5533. PubMed ID: 32591463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired perforin-dependent NK cell cytotoxicity and proliferative activity of peripheral blood T cells is associated with metastatic melanoma.
    Jović V; Konjević G; Radulović S; Jelić S; Spuzić I
    Tumori; 2001; 87(5):324-9. PubMed ID: 11765182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysis.
    He Y; Wang X
    Comput Biol Med; 2023 Dec; 167():107591. PubMed ID: 37875043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.
    Lesinski GB; Kondadasula SV; Crespin T; Shen L; Kendra K; Walker M; Carson WE
    J Natl Cancer Inst; 2004 Sep; 96(17):1331-42. PubMed ID: 15339971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2.
    Sim GC; Wu S; Jin L; Hwu P; Radvanyi LG
    Oncotarget; 2016 Jun; 7(24):36074-36091. PubMed ID: 27153543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis and treatment strategy in melanoma.
    Huang W; Kim BS; Zhang Y; Lin L; Chai G; Zhao Z
    Environ Toxicol; 2024 Mar; ():. PubMed ID: 38530049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.